Inhibition of the renin-angiotensin-aldosterone system: how to obtain this

Curr Pharm Des. 2012;18(7):950-1. doi: 10.2174/138161212799436494.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / drug effects
  • Aging / metabolism
  • Angiotensin Receptor Antagonists / pharmacology
  • Angiotensin Receptor Antagonists / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Animals
  • Autoimmune Diseases / drug therapy
  • Autoimmune Diseases / metabolism
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / prevention & control
  • Diabetes Mellitus, Type 2 / prevention & control
  • Humans
  • Hypertension / drug therapy
  • Hypertension / therapy
  • Inflammation / drug therapy
  • Inflammation / metabolism
  • Mineralocorticoid Receptor Antagonists / pharmacology
  • Mineralocorticoid Receptor Antagonists / therapeutic use
  • Renal Insufficiency, Chronic / drug therapy
  • Renal Insufficiency, Chronic / prevention & control
  • Renin / antagonists & inhibitors
  • Renin-Angiotensin System / drug effects*
  • Renin-Angiotensin System / physiology

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Mineralocorticoid Receptor Antagonists
  • Renin